Comments

Puma Biotechnology

Q: What sector and industry does Puma Biotechnology (PBYI) operate in?

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PBYINASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.95

-0.03-1.01%

At close: -

$3.09

0.144.75%

After Hours: 6:24 PM EDT

Puma Biotechnology (PBYI) Forecast

News Earnings Puma Biotechnology (PBYI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Puma Biotechnology (NASDAQ:PBYI) Stock Quotes, Forecast and News Summary

Puma Biotechnology Stock (NASDAQ: PBYI) stock price, news, charts, stock research, profile.

Open	$2.99
Close	$2.95
Volume / Avg.	284.00K / 587.65K
Day Range	$2.94 - $3.01
52 Wk Range	2.23 - 7.73
Market Cap	$151.68M
P/E Ratio	6.34
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.22%
Days to Cover	5.55

Recent News

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul 24

Aug 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.99
Close	$2.95
Volume / Avg.	284.00K / 587.65K
Day Range	$2.94 - $3.01
52 Wk Range	2.23 - 7.73
Market Cap	$151.68M
P/E Ratio	6.34
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.22%
Days to Cover	5.55

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Puma Biotechnology (PBYI) stock?

You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.

View our list of the best stock brokerages

Who are Puma Biotechnology (PBYI) competitors?

Other companies in Puma Biotechnology’s space includes: Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE) and Adaptimmune Therapeutics (NASDAQ:ADAP).

What is the forecast, or price target, for Puma Biotechnology (PBYI) stock?

Puma Biotechnology has a consensus price target of $7.00.

What is the current price for Puma Biotechnology (PBYI)?

The stock price for Puma Biotechnology (NASDAQ: PBYI) is $3.09 last updated January 22, 2025 at 6:24 PM EST.

Does Puma Biotechnology (PBYI) pay a dividend?

There are no upcoming dividends for Puma Biotechnology.

When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?

Puma Biotechnology’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Puma Biotechnology (PBYI) going to split?

There is no upcoming split for Puma Biotechnology.

What sector and industry does Puma Biotechnology (PBYI) operate in?

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.